Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130205003M |
| Application |
Diabetes Marker |
The kit has been designed for the quantitative determination of Human Insulin Autoantibodies (IAA) in human serum. The method can be used for samples over the range of 2.0-175 IU/ml. The test has to be performed on the Fully-auto chemiluminescence immunoassay (CLIA) analyzer MAGLUMI (Including Maglumi 600,Maglumi 1000,Maglumi 1000 Plus, Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi 4000).
Advanced Technology for Accurate Autoantibody DetectionUtilizing chemiluminescent immunoassay (CLIA) technology, the Snibe MAGLUMI IAA kit ensures high sensitivity and specificity in the detection of Insulin Autoantibodies. Its automated operation streamlines workflows and reduces manual intervention, delivering reliable results suitable for clinical diagnostics. The kit's compatibility with all MAGLUMI series analyzers makes it a versatile choice for clinical laboratories.
Comprehensive Kit Contents and Easy HandlingThe MAGLUMI IAA (CLIA) reagent kit is supplied in clear, colorless liquid vials and comes complete with calibrators, controls, reagents, and a user-friendly instruction manual. The components are stable for 12 months when stored at 2-8C, protected from light and freezing, ensuring consistent quality and performance throughout the kit's shelf life.
Efficient Workflow for Clinical LaboratoriesDesigned for use in laboratory environments, the MAGLUMI IAA kit offers a rapid turnaround time-typically 30 to 40 minutes per analysis, depending on the analyzer configuration. The straightforward process supports real-time operation with automated features, enabling laboratories to deliver results promptly and accurately to clinicians and patients.
FAQ's of Snibe MAGLUMI IAA (CLIA):
Q: How does the Snibe MAGLUMI IAA (CLIA) reagent kit detect Insulin Autoantibodies?
A: The kit uses an indirect two-step chemiluminescent immunoassay (CLIA) to quantitatively measure Insulin Autoantibodies (IAA) in human serum or plasma samples. This advanced methodology ensures high sensitivity and precision in autoantibody detection.
Q: What types of samples can be analyzed with this reagent kit?
A: The MAGLUMI IAA (CLIA) kit is designed for use with human serum or plasma, making it suitable for various clinical sample types encountered in diagnostic laboratories.
Q: When should clinical laboratories choose this kit for IAA testing?
A: This reagent kit is ideal for routine and real-time detection of Insulin Autoantibodies, particularly in settings where rapid, accurate, and automated quantitative results are essential-for example, in diabetes research or screening programs.
Q: Where can the Snibe MAGLUMI IAA (CLIA) kit be used?
A: It is intended for use in clinical laboratories, hospitals, and diagnostic centers equipped with MAGLUMI series CLIA analyzers. The kit is not portable and is not meant for point-of-care or home use.
Q: What is the process for using the MAGLUMI IAA kit?
A: The process includes loading serum or plasma samples and reagents onto the MAGLUMI analyzer, following prompts as outlined in the instruction manual. The analyzer automates the assay-usually delivering results within 30-40 minutes per batch.
Q: How should the kit components be stored to ensure stability?
A: To maintain reagent stability and performance, store all kit components at 2-8C, away from direct light, and avoid freezing. Proper storage preserves the 12-month shelf life specified by the manufacturer.
Q: What are the key benefits of using the MAGLUMI IAA (CLIA) reagent kit?
A: The principal advantages include high sensitivity and specificity, rapid assay turnaround, simple handling with ready-to-use reagents, full automation, and CE-IVD compliance, ensuring reliable results for clinical diagnostics.